Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

87 results about "Elemene" patented technology

Elemenes are a group of closely related natural chemical compounds found in a variety of plants. The elemenes, which include α-, β-, γ-, and δ-elemene, are structural isomers of each other and are classified as sesquiterpenes. The elemenes contribute to the floral aromas of some plants, and are used as pheromones by some insects.

Terpenoid production and strain

The invention discloses production of terpenoids and a strain, and belongs to the technical field of bioengineering. The serratia marcescens engineering bacteria for producing the semi-terpenoids or monoterpenoids are constructed, and can be used for producing linalool, isoprene, isopentenol, 1, 3, 4-triterpenes and 1, 3, 4-triterpenes. The composition is prepared from 1, 8-cineole, alpha-pinene, pinene, gamma-terpinene, geraniol, (+)-limonene, (-)-limonene, myrcene, beta-ocimene, sabinene, (-)-alpha-bisabolol, (-)-alpha-bisabolol, longifolene, wallenenes, beta-elemene, farnesene, patchouli alcohol, acyclic terpene and alpha-santalene. In a 30L fermentation tank, the yield of linalool produced by the serratia engineering bacteria is 40.72 g.L <-1 >.
Owner:XI AN ZHUO HONG CHAO YUAN BIOLOGY SCIENCE & TECHNOLOGY CO LTD

Micro-needle preparation for co-delivering photo-thermal nano-enzyme and elemene as well as preparation method and application of micro-needle preparation

The invention provides a microneedle preparation for co-delivering photo-thermal nano-enzyme and elemene as well as a preparation method and application of the microneedle preparation. The preparation method comprises the following steps: firstly, preparing a novel photo-thermal nano enzyme Au (at) MoS2 through a two-step water phase synthesis strategy; benefited from the synergistic effect of the hybrid material, the nano-enzyme shows significantly enhanced near-infrared (NIR) photothermal effect, peroxidase-like (POD) activity and glutathione-like peroxidase (GSHOx) activity, and can effectively remodel the tumor microenvironment and destroy the redox steady state. Furthermore, photo-thermal nano enzyme, beta-ELE and hyaluronic acid are used as raw materials, and a novel soluble microneedle preparation is successfully prepared through a template method. The novel composite microneedle is in a sharp rectangular pyramid shape, growth of melanoma can be effectively inhibited through percutaneous delivery of photo-thermal nano-enzyme and beta-ELE, remarkable systemic toxicity is avoided, and an innovative strategy is provided for non-invasive, efficient and safe melanoma combined treatment.
Owner:HANGZHOU NORMAL UNIVERSITY

Germacene A synthase mutant, recombinant engineering bacterium and application

The invention relates to the technical fields of bioengineering, synthetic biology, computational biology and the like, in particular to a germacene A synthase mutant, recombinant engineering bacteria and application. The amino acid sequence of the germacene A synthase mutant ScGASY376L is as shown in SEQ ID NO. 1. The germacene A synthase mutant ScGASY376L After the germacene A synthase mutant is transferred into escherichia coli, the yield of the product beta-elemene is detected, and the yield reaches 487.46 mg / L, so that the mutant can be used for modifying engineering strains, and a powerful research basis is provided for high-yield beta-elemene.
Owner:江西省 中国科学院庐山植物园 +1

Saccharomyces cerevisiae recombinant strain for efficiently producing terpenoids as well as construction method and application of saccharomyces cerevisiae recombinant strain

The invention discloses saccharomyces cerevisiae recombinant bacteria for efficiently producing terpenoids as well as a construction method and application of the saccharomyces cerevisiae recombinant bacteria. According to the construction method, saccharomyces cerevisiae rich in terpenoid precursor farnesyl pyrophosphate is taken as a starting strain, the GAL80 protein level in a galactose induction system is regulated and controlled by introducing an N-Degron strategy, and meanwhile, a glucose concentration response type promoter HXT1 is introduced to effectively regulate and control the expression of GAL80 from the transcriptional level; the saccharomyces cerevisiae recombinant strain for efficiently producing the terpenoids can be obtained. The strategy is applied to a saccharomyces cerevisiae engineering strain of beta-elemene and patchouli alcohol, and a remarkable effect is achieved. And in the high-density fermentation process of the saccharomyces cerevisiae, the yield of the beta-elemene is obviously increased and reaches 4818.6 mg / L. The invention provides a solid research basis for sustainable biosynthesis of terpenoids, and has a wide application prospect.
Owner:EAST CHINA UNIV OF SCI & TECH

Application of beta-elemonic acid or derivative thereof in preparation of medicine for preventing and / or treating polycystic ovarian syndrome

The invention belongs to the technical field of biological medicines, and discloses application of beta-elemonic acid or derivatives thereof or pharmaceutically acceptable salts thereof in preparation of medicines for preventing and / or treating polycystic ovarian syndrome (PCOS). The beta-elemonic acid is screened from a medicinal and edible library, and experiments prove that the beta-elemonic acid can remarkably improve the PCOS ovarian form and the number of mature follicles, normalize the disordered estrus cycle, remarkably improve the serum hormone level and further remarkably improve the sugar tolerance, insulin tolerance and weight of PCOS. The beta-elemonic acid disclosed by the invention is a compound based on homology of medicine and food, can be used as a medicine as well as a natural ingredient of food, is relatively low in toxicity, ensures the safety after long-term use, is relatively low in safety evaluation cost of a relatively brand-new synthetic compound, and can be applied to development and preparation of a medicine or a lead compound thereof for preventing and / or treating PCOS, or a health care product.
Owner:GUANGZHOU MEDICAL UNIV

Gammatene A synthase mutant and application thereof

The invention discloses a germacene A synthase mutant and application thereof, and belongs to the technical field of enzyme engineering and microbial engineering. Aiming at the bottleneck of the catalytic efficiency of the germacene A synthase, the optimal germacene A synthase mutant DlGASS32H-I97V-Y315F is obtained through semi-rational design based on sequence conservative analysis by taking the germacene A synthase from fungi with a separation wheel layer carbon shell as an object, and the optimal germacene A synthase mutant DlGASS32H-I97V-Y315F is verified through shake flask fermentation in engineering bacteria saccharomyces cerevisiae, so that the yield of beta-elemene is increased by 24%. The combined mutant obtained through a key gene conserved sequence mutation prediction strategy shows remarkably improved catalytic performance, the effectiveness of guiding an enzyme directed evolution strategy based on multi-species sequence conservative analysis is verified, and the yield of germacene A or beta-elemene is remarkably improved. Meanwhile, the method has the advantages of simplicity and convenience in operation, environmental friendliness, mild reaction conditions and the like, and has a very good application prospect in the field of production of germacene A.
Owner:SOUTH CHINA UNIV OF TECH

Saccharomyces cerevisiae recombinant strain based on uracil metabolism gene URA3 as well as construction method and application of saccharomyces cerevisiae recombinant strain

PendingCN120866093AFungiMicroorganism based processesBiosynthetic genesUracil metabolism
The invention discloses a saccharomyces cerevisiae recombinant strain based on a uracil metabolism gene URA3 as well as a construction method and application of the saccharomyces cerevisiae recombinant strain. The construction method comprises the following steps: taking saccharomyces cerevisiae rich in farnesyl pyrophosphate as an original strain, introducing a uracil metabolism gene URA3, synchronously overexpressing a ribosome biosynthetic gene UTP10 and an iron metabolism gene FIT3, and utilizing the uracil metabolism gene URA3 to express up-regulation correlation with the ribosome biosynthetic gene UTP10 and the iron metabolism gene FIT3, so as to obtain the farnesyl pyrophosphate-rich saccharomyces cerevisiae. The metabolic flux of the terpenoids is enhanced, and the saccharomyces cerevisiae recombinant strain for efficiently producing the terpenoids is constructed. According to the method, a metabolic network of yeast is systematically optimized, and combined regulation and control on precursor flux distribution, protein translation capability and metal ion steady state are realized, so that the microbial synthesis efficiency of sesquiterpenoids such as patchouli alcohol and beta-elemene is remarkably improved.
Owner:EAST CHINA UNIV OF SCI & TECH

Combined medicine for treating cancer

The invention provides a combined medicine for treating cancer, the combined medicine comprises beta elemene and a second medicine, and the second medicine is selected from pemetrexed disodium, zerbutinib and vionetog, and the second medicine comprises beta elemene, beta elemene, beta elemene, beta elemene, beta elemene, beta elemene, beta elemene, beta elemene, beta elemene and beta elemene.
Owner:SICHUAN HONGHE BIOTECHNOLOGY CO LTD

Hydrophobic temperature-sensitive mesoporous silicon drug delivery system as well as preparation method and application thereof

The invention discloses a hydrophobic temperature-sensitive meso-porous silicon drug delivery system and a preparation method and application thereof.The drug delivery system takes copper sulfide nanoparticles as a core and amino-modified hydrophobic meso-porous silicon dioxide as a shell, the surface is coated with a temperature-sensitive polymer PEG-p (AAm-co-AN) coat, and the hydrophobic temperature-sensitive meso-porous silicon drug delivery system is prepared. Wherein the hydrophobic mesoporous silica is prepared from a silane coupling agent A151 containing a carbon-carbon double bond and a silicon source TEOS; the drug delivery system has a photo-thermal effect and upper critical solvent temperature responsiveness, can load a large amount of hydrophobic drugs such as beta-elemene, and can realize controllable release under irradiation of 980nm near-infrared light. The phase change temperature of the delivery system is 43 DEG C, so that the combined application of photo-thermal therapy and chemotherapy can be realized while the drug release is controlled, and a more effective tumor inhibition effect is achieved. In addition, the preparation method is simple and has a wide application prospect.
Owner:HANGZHOU NORMAL UNIVERSITY

Method for producing terpenoids

The invention discloses a method for producing terpenoids, and belongs to the technical field of bioengineering. The serratia marcescens engineering bacteria for producing the semi-terpenoids or monoterpenoids are constructed, and can be used for producing isoprene, isopentenol, 1, 3, 4-triterpenes, 1, 3, 4-triterpenes and the like. The composition is prepared from 1, 8-cineole, alpha-pinene, pinene, gamma-terpinene, geraniol, (+)-limonene, (-)-limonene, myrcene, beta-ocimene, sabinene, (-)-alpha-bisabolol, (-)-alpha-bisabolol, longifolene, wallenenes, beta-elemene, farnesene, patchouli alcohol, acyclic terpene and alpha-santalene. In a 30L fermentation tank, the yield of linalool produced by the serratia engineering bacteria is 13.49 g.L <-1 >.
Owner:XI AN ZHUO HONG CHAO YUAN BIOLOGY SCIENCE & TECHNOLOGY CO LTD

Eelemene hydrogel as well as preparation method and application thereof

The invention belongs to the technical field of medicines, and particularly relates to elemene hydrogel as well as a preparation method and application thereof. The elemene hydrogel provided by the invention comprises a hydrogel matrix and a drug-loaded nano preparation distributed in the hydrogel matrix, the drug-loaded nano preparation comprises a nano delivery carrier and an effective component loaded in the nano delivery carrier, the effective components comprise beta-elemene, an elemene raw material medicine or a medicine pair containing the elemene. According to the elemene hydrogel provided by the invention, the nano delivery carrier is used as a carrier of elemene, so that the hydrophobicity of elemene can be improved so as to be uniformly mixed with a hydrogel matrix, and furthermore, the release of an elemene nano drug is controlled by utilizing the hydrogel to load a drug-loaded nano preparation; according to the elemene hydrogel, release of elemene is controlled at the tumor postoperative site, the tumor cell killing effect is achieved, meanwhile, anti-tumor immunity is enhanced, and the purpose of inhibiting tumor postoperative recurrence and metastasis is achieved.
Owner:HANGZHOU NORMAL UNIVERSITY

Combined medicine for treating cancer

The invention relates to a combined medicine for treating cancer, the combined medicine contains beta elemene, the combined medicine is a single compound preparation or a combination of two single preparations, and the combined medicine effectively realizes the synergism of medicines.
Owner:SICHUAN HONGHE BIOTECHNOLOGY CO LTD

Beta-elemene tryptophan methyl ester derivative and application of beta-elemene tryptophan methyl ester derivative in preparation of antitumor drugs

The invention belongs to the technical field of medicines, and particularly relates to a beta-elemene tryptophan methyl ester derivative and application thereof in preparation of antitumor drugs. According to the beta-elemene tryptophan methyl ester derivative with the structure as shown in the formula (I), on the basis of maintaining a beta-elemene structural framework, a tryptophan methyl ester group is introduced to the 13th site of beta-elemene, and unsubstituted C3-7 heterocycloalkyl, substituted C3-7 heterocycloalkyl, unsubstituted C5-11 hetero-spirocycloalkyl or substituted C5-11 hetero-spirocycloalkyl is introduced to the 14th site of beta-elemene, so that the beta-elemene tryptophan methyl ester derivative with the structure as shown in the formula (I) is obtained. The water solubility and the pharmacokinetic property of the compound are effectively improved. Experimental results show that the anti-tumor activity of the beta-elemene tryptophan methyl ester derivative with the structure as shown in the formula (I) provided by the invention is obviously enhanced compared with that of beta-elemene. Formula (I).
Owner:HANGZHOU NORMAL UNIVERSITY

Elemane colon-targeting nano-capsule, preparation method and use thereof

The application discloses a elemene colon-targeting nano-capsule and a preparation method and application thereof, and belongs to the technical field of pharmaceutical preparations, and comprises a core and a pH-sensitive enteric polymer coated on the surface of the core, wherein the core comprises elemene and a self-nanoemulsifying lipid material, and the self-nanoemulsifying lipid material comprises an oil phase, an emulsifier and a co-emulsifier. The nano-capsule has small particle size, uniform dispersion, a clear capsule structure, high drug loading and high encapsulation efficiency, can protect the drug from being released in advance in the stomach and small intestine, and can be effectively delivered to the colon. Animal experiments show that the nano-capsule releases the drug in the form of nanoemulsion in simulated colon fluid, can significantly inhibit the tumor growth of in-situ tumor-bearing mice, has good biological safety, and significantly improves the anti-colorectal cancer therapeutic effect of the drug.
Owner:ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE

14-chloro-β-elemene nitric oxide donor derivative and preparation method and use thereof

Disclosed are a 14-chloro-β-elemene nitric oxide donor derivative and a preparation method and use thereof in the preparation of anti-tumor drugs. The 14-chloro-β-elemene nitric oxide donor derivative has a general formula shown in formula (I): in formula (I): R1 represents a linear or cyclic alcohol amine structure containing nitrogen and oxygen atoms; and each of R2 and R3 is independently selected from the group consisting of C1-10 alkyl, C3-12 cycloalkyl, C6-12 aryl, 5- to 10-membered cyclic heteroaryl, C2-10 alkenyl, C2-10 alkynyl, and C2-10 alkoxy.
Owner:HANGZHOU NORMAL UNIVERSITY

Beta-elemene synthase and application thereof in preparation of beta-elemene

The invention discloses a beta-elemene synthase and an application of the beta-elemene synthase in preparation of beta-elemene. On the basis of EL-Y0 chassis bacteria of high-yield precursor FPP, ERG20 (FPP synthase) and AarTPS72 (beta-elemene synthase) are subjected to fusion expression through flexible linker (GGGS) 2, and the metabolic flux of an MVA pathway is improved by overexpressing genes HIF-1, UPC2-1 and tHMGR, so that the biosynthesis of beta-elemene is improved; the engineering bacterium EL16 for producing the beta-elemene is successfully obtained; the final shake flask yield of the beta-elemene is 748.1 mg / L; in addition, the engineering bacterium EL16 is used for carrying out fed-batch fermentation in a 5L bioreactor, and the final titer of beta-elemene is 14.60 g / L.
Owner:CHINESE MEDICINE GUANGDONG LABORATORY

An engineered bacterium producing β-elemene and its application

The present invention discloses an engineered bacterium for producing β-elemene and its application. The recombinant bacterium provided by the present invention expresses genes for enzymes related to the IPP and DMAPP biosynthesis pathways, as well as farnesyl pyrophosphate synthase, and a mutant of the lettuce-derived germarene A synthase gene in the host Escherichia coli BL21(DE3)star. The recombinant bacterium can obtain a germarene A precursor after IPTG induction in SBMSN medium, and then generate β-elemene after high-temperature conversion. The time-to-yield reaches the highest level reported to date, providing a useful strain for the biosynthesis of β-elemene.
Owner:HANGZHOU NORMAL UNIVERSITY

Synthase of (-)-gemmarene A and preparation method thereof

The invention relates to a protein for generating (-)-gemmacene A. The protein comprises the following segments: 1) a polypeptide with an amino acid sequence of X1Y1X2Y2W; 2) a polypeptide with an amino acid sequence of X3Y3Y4Y5Y6L; 3) a polypeptide of which the amino acid sequence is LY7Y8Y9X4Y10R; and 4) a polypeptide with an amino acid sequence of Y11Y12Y13X5Y14. The synthesis of the (+)-beta-elemene is effectively realized.
Owner:SICHUAN HONGHE BIOTECHNOLOGY CO LTD

Method for producing beta-elemene through microbial fermentation

The invention belongs to the field of biochemical engineering, and discloses a method for producing beta-elemene through microbial fermentation, which comprises the following steps: carrying out high-pressure sterilization on a culture medium for fermentation and a certain amount of solid phase a before fermentation, inoculating a recombinant strain into fermentation liquor after the temperature is reduced, with the inoculation amount of 1-5% (V / V), and adding IPTG for induction after the OD of the recombinant strain grows to 0.8-2.0, the total amount of the solid phase in the whole reaction system does not exceed 20% (W / V), fermenting until the growth of the recombinant strain declines, after the fermentation is finished, carrying out suction filtration, collecting the added solid phase, washing with water, pouring into a beaker, adding a certain amount of an organic solvent, carrying out ultrasonic extraction, and after the extraction is complete, carrying out vacuum drying to obtain the recombinant strain. And concentrating the organic solvent in a distillation or reduced pressure distillation manner to obtain a beta-elemene crude product. According to the invention, the yield of beta-elemene in escherichia coli is increased, and the cost is reduced for subsequent industrial production.
Owner:DALIAN UNIV

Application of compound in tumor treatment

The invention provides an application of (1R, 2R, 4S)-beta-elemene in tumor treatment and a method for preparing the (1R, 2R, 4S)-beta-elemene, the (1R, 2R, 4S)-beta-elemene is obtained by heating and converting (-)-gemmarene A, and the (-)-gemmarene A is obtained by fermenting engineering bacteria containing nucleotide of enzyme capable of synthesizing the (-)-gemmarene A. The invention further discloses a preparation method of the (1R, 2R, 4S)-beta-elemene and an application of the (1R, 2R, 4S)-beta-elemene.
Owner:SICHUAN HONGHE BIOTECHNOLOGY CO LTD

Use of compound in treatment of tumors

Provided are a use of (1R,2R,4S)-3-elemene in treatment of tumors and a method for preparing (1R,2R,4S)-3-elemene. The (1R,2R,4S)-3-elemene is obtained by heating and converting H-germacrene A, and the H-germacrene A is obtained by means of fermentation of an engineered bacterium containing a nucleotide encoding an enzyme capable of synthesizing (-)-germacrene A.
Owner:SICHUAN HONGHE BIOTECHNOLOGY CO LTD

Biosynthesis of elemene and its application in tea plant resistance to aphids

The invention discloses a biosynthesis of elemene and its application in tea tree anti-aphid, belonging to the field of biotechnology, elemene synthase, and its amino acid sequence is shown in SEQ ID No. 1. By increasing the content of elemene in tea trees, the ability of tea trees to avoid tea aphids is improved. The method of the invention can effectively control aphid pests, protect the growth and development of tea trees, improve the quality and yield of crops, and increase farmers' income.
Owner:ANHUI AGRICULTURAL UNIVERSITY

Recombinant yeast and application thereof in fermentation production of beta-elemene

The invention relates to the technical field of microorganisms, and particularly discloses recombinant saccharomycetes and application thereof in fermentation production of beta-elemene. Compared with a starting yeast strain, the recombinant yeast provided by the invention expresses farnesyl diphosphate synthase ERG20, sesquiterpene synthase LsLTC2 from lettuce and difunctional farnesyl diphosphate synthase RrFPS from rose, and expresses IDI1, ERG13, ERG8, ERG10, ERG12, MVD1 and tHMGR in peroxisome. Preferably, the expression quantity of squalene synthase ERG9 in a cell matrix is further reduced, ERG10, ERG13 and IDI1 are overexpressed, and XFPK, PTA, POXB and ACS are expressed. The recombinant saccharomycetes disclosed by the invention can efficiently produce the beta-elemene, and a more effective method is provided for industrial production of the beta-elemene.
Owner:INSTITUTE OF CHINESE MATERIA MEDICA CHINA ACADEMY OF CHINESE MEDICAL SCIENCES

Recombinant escherichia coli for improving gernial A titer by key enzymes ispA and GAS of protein scaffold cascade pathway and application

The application discloses a kind of recombinant escherichia coli for improving gimalenol A titer by protein scaffold cascade pathway key enzyme IspA and GAS and application thereof, fusion protein is expressed in the recombinant escherichia coli, fusion protein is obtained by four peptide binding modules respectively with pathway key enzyme IspA and GAS cascade, four peptide binding modules are connected to the N terminal of IspA and the C terminal of GAS by connecting peptide, four peptide binding modules are SpyCatcher, SpyTag, SnoopCatcher and SnoopTag;Four peptide binding modules form stable enzyme cascade assembly through specific covalent action, to realize the spatial close-range cascade catalysis of IspA and GAS, improve the synthesis efficiency of gimalenol A, finally by Cope rearrangement gimalenol A is converted into β-elemene.The application uses glycerol as carbon source, realizes the efficient synthesis of gimalenol A by IPTG induction and in-situ extraction, and drives its Cope rearrangement to be converted into β-elemene under high temperature condition.The yield of β-elemene reaches 7.2g / L and 31.2g / L respectively by shake flask and fermenter verification, and the product yield and substrate utilization are improved.
Owner:NANJING FORESTRY UNIV

Germaene A synthase mutant and its application

The present invention belongs to the field of enzyme engineering technology, and specifically relates to a mutant of germaene A synthase and its application. The present invention obtains a series of chicory-derived germaene A synthase (CiGASlo) mutants by computer-aided design, constructs CiGASlo mutants by point mutation PCR method, further expresses recombinant protein and purifies, verifies enzyme activity by in vitro enzymatic reaction, and thus screens out CiGASlo mutants with significantly improved relative enzyme activity. The present invention can provide a CiGASlo mutant with significantly improved catalytic activity, which is helpful to promote and apply in the industrial production process of sesquiterpene compounds such as β-elemene. The present invention has the advantages of mild reaction conditions, high stereoselectivity, simple catalyst treatment steps, and environmental friendliness, and reduces equipment requirements, significantly reduces production costs, and shows a wide range of application prospects in industrial applications.
Owner:HANGZHOU NORMAL UNIVERSITY

Novel procaspase-3 activators and uses thereof

This invention belongs to the field of pharmaceutical technology, specifically relating to a series of novel Procaspase-3 activators and their application in the preparation of various malignant tumor drugs. One novel Procaspase-3 activator is a compound of Formula 1 and its salt. The β-elemene-structured Procaspase-3 activator described in this invention aims to activate the activity of Procaspase-3, which is highly expressed in various tumor cells, and induce tumor cell apoptosis restart. These new compounds exhibit stronger physiological activity and stability.
Owner:SHENYANG PHARMA UNIV

Hydrophobic temperature-sensitive mesoporous silica drug delivery system and preparation method and application thereof

The application discloses a hydrophobic temperature-sensitive mesoporous silica drug delivery system and a preparation method and application thereof, and the drug delivery system takes copper sulfide nanoparticles as a core, takes amino-modified hydrophobic mesoporous silica as a shell, and is coated with a surface coating of a temperature-sensitive polymer PEG-p(AAm-co-AN), wherein the hydrophobic mesoporous silica is prepared from silane coupling agent A151 containing a carbon-carbon double bond and a silicon source TEOS; the drug delivery system has photothermal effect and upper critical solution temperature responsiveness, can load a large amount of hydrophobic drugs such as beta-elemene, and can realize controllable release under 980nm near-infrared light irradiation. The phase transition temperature of the delivery system is 43 DEG C, so that the combination of photothermal therapy and chemotherapy can be realized while the drug release is controlled, so as to achieve more effective tumor inhibition. In addition, the preparation method is simple and has wide application prospect.
Owner:HANGZHOU NORMAL UNIVERSITY

A beta-elemene-based cervical cancer treatment composition and a preparation method thereof

This invention relates to the field of antitumor drug technology, and discloses a cervical cancer treatment composition based on β-elemene and its preparation method. The composition comprises β-elemene, dimethyl sulfoxide (DMSO), and a diluent matrix; wherein the final concentration of β-elemene is 10 μg / mL to 50 μg / mL, and the volume percentage of DMSO is constant at 0.4% to 0.6%. The preparation method includes preparing a stock solution and preparing the final product. By dynamically adjusting the volume of DMSO added, the total amount of solvent in the composition at different drug concentrations remains constant, thus establishing a strict single-variable evaluation system for in vitro drug delivery. This invention effectively eliminates the cytotoxicity additive interference caused by fluctuations in the amount of solubilizer in conventional drug delivery systems, prevents the aggregation and precipitation of poorly soluble components in the aqueous phase, and can objectively and accurately reflect the true pharmacological activity of β-elemene in inhibiting cervical cancer cells and inducing ferroptosis.
Owner:DAZHOU VOCATIONAL COLLEGE OF TRADITIONAL CHINESE MEDICINE